Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...
Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...
Despite an ongoing battle with chronic pain, the father of two is fundraising for Stand Up to Cancer – a joint fundraising campaign from Cancer Research UK and Channel 4. READ MORE: Andrew, who has ...